Priporočila za obravnavo diareje ob sistemskem onkološkem zdravljenju

Show document
A+ | A- | | SLO | ENG

Title:	Priporočila za obravnavo diareje ob sistemskem onkološkem zdravljenju
Authors:	ID Hribernik, Nežka (Author) ID Reberšek, Martina (Author)
Files:	PDF - Presentation file, download (446,90 KB) MD5: 9CA7CBBA8F8FE8EDBBA2047ABFBF0DAB PID: 20.500.12556/dirros/12307a36-13b6-481c-a1d3-b1dc345206f9
Language:	Slovenian
Typology:	1.04 - Professional Article
Organization:	OI - Institute of Oncology
Keywords:	diareja, bolniki, onkološki bolniki, sistemsko zdravljenje
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2014
Number of pages:	str. 102-104, 119
Numbering:	Letn. 18, št. 2
PID:	20.500.12556/DiRROS-9058
UDC:	616-006
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-1H6ZBV3U
COBISS.SI-ID:	1963899
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	3089
Downloads:	750
Metadata:
:	Copy citation

Share:

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Onkologija. strokovni časopis za zdravnike
Shortened title:	Onkologija
Publisher:	Onkološki inštitut
ISSN:	1408-1741
COBISS.SI-ID:	65324032

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	Undetermined
Title:	Recommendations for diarrhea in systemic oncology treatment
Abstract:	Diarrhea is defined as frequent passages of loose, unformed or liquid stool more than three times in 24 hours. It is one of the most common undesirable symptoms, which oncology patients face. Diarrhea can lead to dehydration, electrolytic and metabolic disorders, kidney failure and in severe cases also hemodynamic instability, which requires hospitalisation. The problem can affect the uninterrupted course of a specific cancer treatment and influence the quality of life of patients, reduce compliance to treatment and shorten the survival period. General recommendations for diarrhea in cancer treatment were first published in 1998, amended and adapted in 2004 in the Journal of Clinical Oncology (1). So far there are no updated, internationally accepted instructions. The article summarises the recognised and generally adopted recommendations, with differences in treatments of diarrhea with cytostatic and target medications.